By applying existing drug products to new diseases and applications (drug repurposing) you can bring new therapies to patients faster.
Dr. Manoe Janssen from the Therapy Accelerator for Rare Diseases and Professor Peter-Bram ‘t Hoen from the Department of Medical BioSciences will discuss the computational and experimental strategies that you can use to identify affected pathways and select existing drug compounds to treat your disease of interest.
Bring your own questions and projects to present during the Q&A to get input on your own therapy development project
-
25 of June 9:00-10:30 Keizer Karel, route 7 Experience center
-
- Advantages of drug repurposing in therapy development – Manoe Janssen
- How to identify and evaluate promising drug candidates for your disease of interest – Peter-Bram ’t Hoen
- What are your needs? Bring your own drug repurposing questions to the table
-
Are you interested in joining? Please register in time, as places are limited.
Registration link: Invullen | Registration form - Meet the Expert session
To stay updated on future events join our new Teams channel on therapy development for preclinical researchers: From model to therapy